Viewing Study NCT07322003


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-30 @ 1:12 AM
Study NCT ID: NCT07322003
Status: RECRUITING
Last Update Posted: 2026-02-27
First Post: 2026-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Sponsor: Prilenia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module